Clinical Trial Update: Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial evaluating defactinib and avutometinib, with or without encorafenib, in patients with brain metastases from cutaneous melano…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Cutaneous Melanoma

Drugs mentioned

• Avutometinib (avutometinib)
• Defactinib (defactinib)
• Encorafenib (encorafenib)

Snippet

Sponsor: University of Utah | Conditions: Cutaneous Melanoma, Brain Metastases | Phase 1, Phase 2 | Status: RECRUITING